Welcome to Anavex Life Sciences Corp.

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.


 

Webcast
Anavex corporate presentation at 17th Annual BIO CEO & Investor Conference on February 10, 2015

Interview

Interview
Equities.com speaks with Christopher Missling, PhD., President and CEO of Anavex.